FIELD: medicine.
SUBSTANCE: method for detecting a human folic acid receptor 1 (hereinafter – FOLR1) in a biological sample is proposed, including the capture of the specified FOLR1 using an immuno-capture reagent bound to solid substrate, elution of FOLR1 from solid substrate, cleavage of eluted FOLR1 and analysis of cleaved FOLR1 by liquid chromatography and mass spectrometry.
EFFECT: invention makes it possible to detect lower levels of FOLR1 in a biological sample.
24 cl, 4 dwg, 8 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DIAGNOSTIC ANALYSES AND KITS FOR DETECTION OF FOLATE RECEPTOR 1 | 2018 |
|
RU2788126C2 |
| ANTIBODIES AGAINST FOLIC ACID RECEPTOR 1, THEIR IMMUNOCONJUGATES AND USE | 2011 |
|
RU2740479C2 |
| COMBINATION THERAPY BASED ON T-CELL-ACTIVATING BISPECIFIC ANTIGEN-BINDING MOLECULES AGAINST CD3 AND FOLATE RECEPTOR 1 (FOLR1) AND ANTAGONISTS BINDING TO PD-1 AXIS | 2015 |
|
RU2753902C2 |
| ANTIBODIES AND ANALYSIS METHODS FOR FOLIC ACID 1 RECEPTOR DETECTION | 2014 |
|
RU2725825C2 |
| IMPROVED ANTIGEN-BINDING RECEPTORS | 2018 |
|
RU2825816C2 |
| TUMOR-TARGETED AGONISTIC CD28-ANTIGEN-BINDING MOLECULES | 2019 |
|
RU2808030C2 |
| ANTI-LILRB1 ANTIBODY AND USES THEREOF | 2021 |
|
RU2813373C1 |
| PROCOAGULANT ANTIBODIES | 2018 |
|
RU2810094C2 |
| HIGH-AFFINITY ANTI-PD-1 AND ANTI-LAG-3 ANTIBODIES AND BISPECIFIC BINDING PROTEINS OBTAINED FROM THEM | 2019 |
|
RU2782381C2 |
| ANTIBODIES AGAINST HLA-G, COMPOSITIONS CONTAINING ANTIBODIES AGAINST HLA-G, AND METHODS OF USE OF ANTIBODIES AGAINST HLA-G | 2019 |
|
RU2810326C2 |
